Stocks TelegraphStocks Telegraph
Stock Ideas

EKSO Stock Performance and Key Statistics

NASDAQ : EKSO

Ekso Bionics

$8.64
-1.94-18.34%
At Close 4:00 PM
67.67
BESG ScoreESG Rating

stock performance chart

EKSO Fundamental Analysis

Based on recent data, Ekso Bionics Holdings, Inc. (EKSO) shows an Average True Range (ATR) of 0.84 and an Enterprise Value of 19.66M. Its average trading volume over the past 3 months is 1.89M, indicating liquidity. These fundamental metrics provide insight into EKSO's underlying financial health and market activity.

ATR0.84
Enterprise Value19.66M
Avg Vol (3 Months)1.89M
Avg Vol (10 Days)22.61M

EKSO Technical Analysis Indicators

Ekso Bionics Holdings, Inc. (EKSO) technical indicators as of December 31, 2025: the SMA 20 is 107%, SMA 50 at 116.25%, and SMA 200 at 122.1%. The RSI 14 value is 90.74, suggesting its current momentum. These technical analysis signals help assess EKSO's price trends and potential future movements.

SMA 20107%
SMA 50116.25%
SMA 200122.1%
RSI 1490.74

EKSO Stock Performance Overview

Ekso Bionics Holdings, Inc. (EKSO) stock performance overview as of December 31, 2025: The 52-week high is $224.625 (currently -29.35% below), and the 52-week low is $2.73 (currently 287.55% above). Over the past year, EKSO's performance is -92.23%, compared to the S&P 500's 12.29% change.

52-Week High224.625
52-Week High Chg-29.35%
52-Week Low2.73
52-Week Low Chg+287.55%
S&P 500 52-Week Chg12.29%

Ekso Bionics Holdings, Inc. (EKSO) Historical Stock Performance

According to market data, Ekso Bionics Holdings, Inc. (EKSO) stock's recent performance metrics show that over the last month, EKSO is 136.69%, with a Year-to-Date (YTD) performance of -92.29%. Over the past year, the stock has seen a -92.23% change. These figures summarize EKSO's price movements across various periods, reflecting its historical returns.

Period1 Week1 MonthQuarterHalf Year1 YearYTD
High12.712.712.712.7224.625224.625
Low5.163.513.512.912.732.73
Performance+100.76%+136.69%+93.77%+221.58%-92.23%-92.29%

Industry Analysis and Valuation

According to current financial data, EKSO stock's P/E (TTM) ratio is -1.39, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for EKSO, including P/S (0.99), P/B (1.50), and P/FCF (-1.64), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.

ValuationEKSOSector MedianIndustry AvgS&P 500
P/E (TTM)-1.39-1.248.4832.59
P/S (TTM)0.993.7144.475.98
P/B (TTM)1.50.110.045.81
P/FCF (TTM)-1.64-8.79-50.8434.06

Frequently Asked Questions

How is EKSO price-to-earnings ratio currently?
EKSO has a current P/E ratio of -1.39
How are EKSO's price-to-sale and price-to-book ratios?
The EKSO stock has a trailing twelve month price-to sales (P/S) ratio of 0.99 while its price-to-book (P/B) value is 1.5.
Is Ekso Bionics Holdings, Inc.'s price-to-cashflow ratio high or low?
EKSO's price-to-free-cashflow (P/FCF) ratio is -1.64, an indicator that is currently being trending upward.
What's current simple moving average (SMA) for EKSO?
Based on EKSO's recent bid, its distance from 20 days simple moving average is 107%. It is 116.25% apart from 50 days simple moving average, and it is 122.1% apart from 200 days simple moving average.
What is the 52-week price range for EKSO?
The 52-week high for EKSO is $14.97 which is -29.35% away from the current price level whereas the distance of that from the 52-week low of $2.73 stands at 287.55%.
An overview of EKSO's stock performance: how did it fare?
The performance of EKSO stock was not encouraging with most of its significant price indicators in red. Ekso Bionics Holdings, Inc.(NASDAQ: EKSO) shares have moved downward -18.34% or - $1.94 in the latest trading session and have lost -92.29% year-to-date (YTD). The stock has lost nearly -92.23% over the past year. After moving 93.77% over the trailing 3-month period, the stock is 221.58% higher in the 6-month period. Looking at its performance over the shorter term, it'sgained 100.76% a week and 136.69% a month.
What is EKSO's 14-day relative strength index (RSI)?
The current 14-day RSI for EKSO stock is 90.74. Investors and traders alike rely on the relative strength index, or RSI, as an oscillating indicator. In terms of values, the RSI operates within a range ranging from 0 to 100. A rising RSI line indicates strength in the shares. As the RSI line falls, the opposite occurs. It is possible to examine different time periods when using the RSI indicator. Shorter time frames can cause the RSI to be more volatile. Most traders pay close attention to the marks between 30 and 70 on the RSI scale. When the stock price moves over 70, it is often considered to be an indicator of overbought conditions. Dropping below 30 indicates oversold territory. These levels are often used by traders to forecast stock price reversals.
For EKSO, what is the average true range (ATR) for the past two weeks?
ATR stands for Average True Range, which may be useful when traders or investors are assessing technical inventory. Currently, Ekso Bionics Holdings, Inc. (EKSO) has a 14-day ATR of 0.84.
What is EKSO's current enterprise value?
After closing at $10.58 with 2.62M of its shares outstanding, the current enterprise value of EKSO is roughly 19.66M.
Over the past year, how has the stock price of EKSO changed?
Ekso Bionics Holdings, Inc. (NASDAQ: EKSO) is down -92.23% when it comes to the percentage price change over the past 52-weeks. The percentage price change came less than that of broader S&P 500 index that came at a fall of 12.29%. EKSO stock price is also down -92.29% on its value in year-to-date trading.
What is the average trading volume for EKSO shares?
The number outstanding shares of EKSO is 2.62M, and of these 83.29% shares are freely available for trading. On average, EKSO stock has traded 22.61M shares per day for the past 10 days. A total of 3.66M shares changed hands during the last trading session with the average session volume of 1.93M shares.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph